Scharff MD - Search Results

1

Serum therapy revisited: animal models of infection and development of passive antibody therapy.

Casadevall A, Scharff MD. Casadevall A, et al. Among authors: scharff md. Antimicrob Agents Chemother. 1994 Aug;38(8):1695-702. doi: 10.1128/AAC.38.8.1695. Antimicrob Agents Chemother. 1994. PMID: 7985997 Free PMC article. Review. No abstract available.

2

Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

Mukherjee J, Zuckier LS, Scharff MD, Casadevall A. Mukherjee J, et al. Among authors: scharff md. Antimicrob Agents Chemother. 1994 Mar;38(3):580-7. doi: 10.1128/AAC.38.3.580. Antimicrob Agents Chemother. 1994. PMID: 8203858 Free PMC article.

3

T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice.

Yuan RR, Casadevall A, Oh J, Scharff MD. Yuan RR, et al. Among authors: scharff md. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2483-8. doi: 10.1073/pnas.94.6.2483. Proc Natl Acad Sci U S A. 1997. PMID: 9122221 Free PMC article.

4

Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, Lendvai N, Mukherjee J, Pirofski LA, Rivera J, Rosas AL, Scharff MD, Valadon P, Westin K, Zhong Z. Casadevall A, et al. Among authors: scharff md. Antimicrob Agents Chemother. 1998 Jun;42(6):1437-46. doi: 10.1128/AAC.42.6.1437. Antimicrob Agents Chemother. 1998. PMID: 9624491 Free PMC article.

5

Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.

Mukherjee J, Feldmesser M, Scharff MD, Casadevall A. Mukherjee J, et al. Among authors: scharff md. Antimicrob Agents Chemother. 1995 Jul;39(7):1398-405. doi: 10.1128/AAC.39.7.1398. Antimicrob Agents Chemother. 1995. PMID: 7492075 Free PMC article.

6

A requirement for FcγR in antibody-mediated bacterial toxin neutralization.

Abboud N, Chow SK, Saylor C, Janda A, Ravetch JV, Scharff MD, Casadevall A. Abboud N, et al. Among authors: scharff md. J Exp Med. 2010 Oct 25;207(11):2395-405. doi: 10.1084/jem.20100995. Epub 2010 Oct 4. J Exp Med. 2010. PMID: 20921285 Free PMC article.

7

Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.

Shapiro S, Beenhouwer DO, Feldmesser M, Taborda C, Carroll MC, Casadevall A, Scharff MD. Shapiro S, et al. Among authors: scharff md. Infect Immun. 2002 May;70(5):2598-604. doi: 10.1128/IAI.70.5.2598-2604.2002. Infect Immun. 2002. PMID: 11953401 Free PMC article.

8

Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody.

Yuan R, Casadevall A, Spira G, Scharff MD. Yuan R, et al. Among authors: scharff md. J Immunol. 1995 Feb 15;154(4):1810-6. J Immunol. 1995. PMID: 7836766

9

Cryptococcus neoformans infection can elicit protective antibodies in mice.

Mukherjee J, Scharff MD, Casadevall A. Mukherjee J, et al. Among authors: scharff md. Can J Microbiol. 1994 Oct;40(10):888-92. doi: 10.1139/m94-141. Can J Microbiol. 1994. PMID: 8000967

10

Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.

Mukherjee S, Lee S, Mukherjee J, Scharff MD, Casadevall A. Mukherjee S, et al. Among authors: scharff md. Infect Immun. 1994 Mar;62(3):1079-88. doi: 10.1128/iai.62.3.1079-1088.1994. Infect Immun. 1994. PMID: 8112842 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page